Susan Haigney

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Articles

Aiding Regulatory Submissions Through Robust Bioanalytical Studies

A thorough understanding of both regulatory requirements and study challenges can help develop and validate the appropriate methods for a bioanalytical study program.

Scaling Up Cell Therapies Capacity

Outsourcing partners are ready to fill the market need for greater cell therapies capacities.

Technology and CAPA

Performing corrective action and preventive action (CAPA) activities is often necessary to investigate a manufacturing deviation and prevent it from reoccurring. BioPharm International asked Joe O’Gorman, head of Global Operations at LZ Lifescience, a Cognizant Company, about the role technology plays in performing CAPAs.